CVS Health Corp. closed 5.34% short of its 52-week high of $85.15, which the company reached on October 29th.

If you are wondering whether CVS Health at around US$80.42 is offering fair value or a potential bargain, it helps to break ...

In the last year, multiple insiders have substantially increased their holdings of CVS Health Corporation stock, indicating ...

In the latest trading session, CVS Health (CVS) closed at $79.79, marking a -1.13% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.34% for the day. At the ...

CVS Health’s CVS stock has gained strong momentum so far in 2025, rising 47.1%. While operating income declined nearly 5% in the fourth quarter of 2024 (as reported last month), impacted by continued ...

Despite a >10% rise in CVS Health's stock price from my initial BUY recommendation, CVS Health is downgraded to Hold due to substantial political risks and declining cash flow. CVS faces significant ...

CVS has been worst hit by the rising healthcare utilization/ medical costs, as observed in the relatively higher medical benefit ratio in FQ4'24/ FY2024 compared to its peers. Even so, we believe that ...

The three healthcare conglomerates control over 80% of America’s prescription drug market through their PBM subsidiaries: Optum Rx, CVS Caremark, and Evernorth Express Scripts. Their parent companies ...

CVS Health CVS shares have rallied nearly 38% so far this month, driven by the company’s stronger-than-expected first-quarter 2025 results. Despite concerns over the company’s decision to implement ...

Shares of CVS Health were headed for their best day in more than five months as all of its business segments saw double-digit percentage revenue growth Shares of CVS Health Corp. shot higher in early ...

CVS Group plc ( ($GB:CVSG) ) has provided an update. CVS Group plc has continued its existing share buyback programme by purchasing 15,144 ...